Plasma Leptin and its Relationship with Lipid Peroxidation and Nitric Oxide in Obese Female Patients with or without Hypertension

Archives of Medical Research

Volumn 37, Issue 5, 2006, Pages 602-606

  Konukoglu, Dildar ^a   Serin, Ozden ^b   Turhan, Mehtap Sultan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Taksim Education and Training Hospital   (Turkey)

Author keywords

Atherosclerosis; Leptin; Nitric oxide; Obesity; Oxidative stress

Indexed keywords

FREE RADICAL; LEPTIN; LIPID; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MODEL; ENZYMATIC ASSAY; FEMALE; GROUPS BY AGE; HORMONE BLOOD LEVEL; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; METABOLITE; MULTIVARIATE ANALYSIS; NORMOTENSIVE HYDROCEPHALUS; OBESITY; OXIDATIVE STRESS; REGRESSION ANALYSIS; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ATHEROSCLEROSIS; FEMALE; HUMANS; HYPERTENSION; LEPTIN; LIPID PEROXIDATION; MIDDLE AGED; NITRIC OXIDE; OBESITY; OXIDATIVE STRESS;

EID: 33747077266     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.12.002     Document Type: Article

References (29)

1. Auwerx J., and Staels B. Leptin. Lancet 351 (1998) 737-742
2. Hall J.E., Hildebrandt D.A., and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14 (2001) 103S-115S
3. Bouloumi{dotless}e A., Marumo T., Lafontan M., and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
4. Vecchione C., Maffei A., Colella S., Aretini A., Poulet R., Frati G., et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51 (2002) 168-173
5. Esterbauer H., Wag G., and Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 49 (1993) 566-576
6. Kennedy A., Getty T.W., Watson P., Wallace P., Ganaway E., Pan Q., et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin resistance, and energy expenditure. J Clin Endocrinol Metab 82 (1997) 1293-1300
7. Konukoglu D., Serin O., and Ercan M. Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy. Maturitas 36 (2000) 203-207
8. World Health Organization. WHO document. Measuring obesity-classification and description of anthropometric data. Copenhagen: WHO Regional Office for Europe, Nutrition Unit EUR/ICP/NUT 1998; 125.
9. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
10. Wilding J.P. Leptin and the control of obesity. Curr Opin Pharmacol 1 (2001) 656-661
11. Shek E.W., Brands M.W., and Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 31 (1998) 409-414
12. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., and Sivitz W.I. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 100 (1997) 270-278
13. Corica F., Corsonello A., Ientile R., De Gregorio T., Malara A., Artemisia A., et al. Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women. Am J Hypertens 14 (2001) 619-626
14. Sheu W.H., Lee W.J., and Chen Y.T. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertension 17 (1999) 1289-1295
15. Schulze P.C., and Lee R.T. Oxidative stress and atherosclerosis. Curr Atheroscler Rep 7 (2005) 242-248
16. Beltowski J., Wojcicka G., and Borkowska E. Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 10 (2002) 939-946
17. Yamagishi S., Amano S., Inagak Y., Okamoto T., Takeuchi M., and Inoue H. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 65 (2003) 186-190
18. Nakanishi S., Yamane K., Kamei N., Hideki N., Okubo M., and Kohno N. A protective effect of adinopectin against oxidative stress in Japanese Americans: the association between adinopectin or leptin and urinary isoprostane. Metabolism 54 (2005) 194-199
19. Porreca E., Di Febbo C., Moretta V., Angelini A., Guglielmi M.D., Di Nisio M., et al. Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 175 (2004) 139-143
20. Ross R. Atherosclerosis; an inflammatory disease. N Engl J Med 340 (1999) 115-126
21. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276 (2001) 25096-25100
22. Santos-Alvarez J., Goberna R., and Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194 (1999) 6-11
23. Li H., and Forstermann U. Nitric oxide in pathogenesis of vascular disease. J Pathol 190 (2000) 224-254
24. Jeremy J.Y., Yim A.P., Wan S., and Angelini G.D. Oxidative stress, nitric oxide, and vascular disease. J Card Surg 17 (2002) 324-327
25. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48 (1999) 903-908
26. Ding Y., Vaziri N.D., Coulson R., Kamana V.S., and Roh D.D. Effects of stimulated hyperglycemia, insulin, and glucagons on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 279 (2000) E11-E17
27. Golan E., Tal B., Dror Y., Korzets Z., Vered Y., Weiss E., et al. Reduction in resting metabolic rate and ratio of plasma leptin urinary nitric oxide: influence on obesity-related hypertension. Isr Med Assoc J 4 (2002) 426-430
28. Beltowski J., Wojcicka G., Marciniak A., and Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 74 (2004) 2987-3000
29. Boger R.H., Bode-Boger S.M., and Frolich J.C. The arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis 1271 (1996) 1-11